Literature DB >> 16720365

Negative regulation of T-cell receptor activation by the cAMP-PKA-Csk signalling pathway in T-cell lipid rafts.

Kjetil Tasken1, Anja Ruppelt.   

Abstract

Spatial organization of signal proteins in specialized cholesterol and glycosphingolipid-enriched microdomains (lipid rafts) provide specificity in lymphocyte signalling. Src kinases associate with lipid rafts on the basis of their dual acylation in the N-terminus and initiate T cell signalling. The immunomodulatory signal enzyme protein kinase A (PKA) is a serine/threonine kinase that controls a number of processes important for immune activation by phosphorylation of substrates that alters protein-protein interactions or changes the enzymatic activity of target proteins in T cells. PKA substrates involved in immune activation include transcription factors, members of the MAP kinase pathway, phospholipases and the Src kinase Csk. The PKA type I isoenzyme localizes to lipid rafts during T cell activation and modulates directly the proximal events that take place after engagement of the T cell receptor. The most proximal and major target for PKA phosphorylation is the C-terminal Src kinase Csk which initiates a negative signal pathway that fine-tunes the T cell activation process.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16720365     DOI: 10.2741/2022

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  11 in total

1.  A-kinase anchoring proteins regulate compartmentalized cAMP signaling in airway smooth muscle.

Authors:  Sarah J Horvat; Deepak A Deshpande; Huandong Yan; Reynold A Panettieri; Juan Codina; Thomas D DuBose; Wenkuan Xin; Thomas C Rich; Raymond B Penn
Journal:  FASEB J       Date:  2012-05-30       Impact factor: 5.191

2.  The Alzheimer's Disease-Associated Protein BACE1 Modulates T Cell Activation and Th17 Function.

Authors:  Gerard Hernandez-Mir; Itay Raphael; Shankar Revu; Catherine H Poholek; Lyndsay Avery; William F Hawse; Lawrence P Kane; Mandy J McGeachy
Journal:  J Immunol       Date:  2019-06-17       Impact factor: 5.422

3.  Elevated Cyclic AMP Inhibits Mycobacterium tuberculosis-Stimulated T-cell IFN-γ Secretion Through Type I Protein Kinase A.

Authors:  Yoon-Tae Chung; Virginia Pasquinelli; Javier O Jurado; Xisheng Wang; Na Yi; Peter F Barnes; Veronica E Garcia; Buka Samten
Journal:  J Infect Dis       Date:  2018-05-05       Impact factor: 5.226

Review 4.  Cyclic AMP: a selective modulator of NF-κB action.

Authors:  Sarah Gerlo; Ron Kooijman; Ilse M Beck; Krzysztof Kolmus; Anneleen Spooren; Guy Haegeman
Journal:  Cell Mol Life Sci       Date:  2011-07-09       Impact factor: 9.261

5.  Receptor desensitization and blockade of the suppressive effects of prostaglandin E(2) and adenosine on the cytotoxic activity of human melanoma-infiltrating T lymphocytes.

Authors:  Yunyun Su; Edwin K Jackson; Elieser Gorelik
Journal:  Cancer Immunol Immunother       Date:  2010-10-20       Impact factor: 6.968

Review 6.  Polymer genomics: an insight into pharmacology and toxicology of nanomedicines.

Authors:  Alexander V Kabanov
Journal:  Adv Drug Deliv Rev       Date:  2006-10-06       Impact factor: 15.470

7.  Cyclic adenosine monophosphate involvement in low-dose cyclophosphamide-reversed immune evasion in a mouse lymphoma model.

Authors:  Ai-Xia Dou; Li-Li Feng; Xiao-Qian Liu; Xin Wang
Journal:  Cell Mol Immunol       Date:  2012-09-24       Impact factor: 11.530

Review 8.  Regulation of T cells in airway disease by beta-agonist.

Authors:  Matthew J Loza; Raymond B Penn
Journal:  Front Biosci (Schol Ed)       Date:  2010-06-01

9.  Beta-2 adrenergic receptors increase TREG cell suppression in an OVA-induced allergic asthma mouse model when mice are moderate aerobically exercised.

Authors:  Kari J Dugger; Taylor Chrisman; Sarah L Sayner; Parker Chastain; Kacie Watson; Robert Estes
Journal:  BMC Immunol       Date:  2018-02-17       Impact factor: 3.615

10.  Profiling of human lymphocytes reveals a specific network of protein kinases modulated by endurance training status.

Authors:  Katharina Alack; Astrid Weiss; Karsten Krüger; Mona Höret; Ralph Schermuly; Torsten Frech; Martin Eggert; Frank-Christoph Mooren
Journal:  Sci Rep       Date:  2020-01-21       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.